As of 2026-06-15, the Relative Valuation of Praxis Precision Medicines Inc (PRAX) is (242.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 266.58 USD, the upside of Praxis Precision Medicines Inc based on Relative Valuation is -190.8%.
The range of the Relative Valuation is (220.19) - (262.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 24.6x | 20.8x |
| Forward P/E multiples | 18.8x - 22.4x | 20.6x |
| Fair Price | (220.19) - (262.35) | (242.15) |
| Upside | -182.6% - -198.4% | -190.8% |
| Date | P/E |
| 2026-06-12 | -22.76 |
| 2026-06-11 | -21.17 |
| 2026-06-10 | -20.55 |
| 2026-06-09 | -21.37 |
| 2026-06-08 | -21.62 |
| 2026-06-05 | -21.69 |
| 2026-06-04 | -22.60 |
| 2026-06-03 | -23.82 |
| 2026-06-02 | -22.04 |
| 2026-06-01 | -28.62 |
| 2026-05-29 | -29.88 |
| 2026-05-28 | -30.11 |
| 2026-05-27 | -30.49 |
| 2026-05-26 | -29.93 |
| 2026-05-22 | -29.33 |
| 2026-05-21 | -29.93 |
| 2026-05-20 | -28.66 |
| 2026-05-19 | -27.37 |
| 2026-05-18 | -27.37 |
| 2026-05-15 | -29.25 |
| 2026-05-14 | -29.50 |
| 2026-05-13 | -29.61 |
| 2026-05-12 | -29.30 |
| 2026-05-11 | -28.33 |
| 2026-05-08 | -28.18 |
| 2026-05-07 | -28.46 |
| 2026-05-06 | -28.87 |
| 2026-05-05 | -28.46 |
| 2026-05-04 | -28.83 |
| 2026-05-01 | -27.68 |
| 2026-04-30 | -27.22 |
| 2026-04-29 | -27.59 |
| 2026-04-28 | -27.49 |
| 2026-04-27 | -28.26 |
| 2026-04-24 | -29.44 |
| 2026-04-23 | -28.14 |
| 2026-04-22 | -28.80 |
| 2026-04-21 | -29.10 |
| 2026-04-20 | -29.25 |
| 2026-04-17 | -29.24 |
| 2026-04-16 | -27.36 |
| 2026-04-15 | -29.02 |
| 2026-04-14 | -29.34 |
| 2026-04-13 | -27.07 |
| 2026-04-10 | -26.99 |
| 2026-04-09 | -27.34 |
| 2026-04-08 | -27.34 |
| 2026-04-07 | -26.19 |
| 2026-04-06 | -26.48 |
| 2026-04-02 | -26.50 |